<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
65293-004-03
</NDCCode>
<PackageDescription>
3 VIAL, GLASS in 1 CARTON (65293-004-03) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS (65293-004-01)
</PackageDescription>
<NDC11Code>
65293-0004-03
</NDC11Code>
<ProductNDC>
65293-004
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Orbactiv
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Oritavancin
</NonProprietaryName>
<DosageFormName>
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
</DosageFormName>
<RouteName>
INTRAVENOUS
</RouteName>
<StartMarketingDate>
20140901
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
NDA
</MarketingCategoryName>
<ApplicationNumber>
NDA206334
</ApplicationNumber>
<LabelerName>
The Medicines Company
</LabelerName>
<SubstanceName>
ORITAVANCIN
</SubstanceName>
<StrengthNumber>
400
</StrengthNumber>
<StrengthUnit>
mg/1
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2014-09-12
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag/>
<ListingRecordCertifiedThrough/>
<StartMarketingDatePackage/>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>